Skip to content
Screener

Bioventus BVS Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Globus Medical logo
Globus MedicalGMED
$111.19M-8.2%
Alphatec Holdings logo
Alphatec HoldingsATEC
$29.65M-9.8%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$7.35M+339%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$144.93K-24.2%
IAR
Integra LifeSciencesIART
$176.58M+1.8%

Other financials

Income statement

See full
Revenue$153.2M+3.8%
Gross profit$105.7M+3.5%
Operating income$19.1M+4.1%
Net income$33.4M+348%
EPS (diluted)$0.47+327%

Balance sheet

See full
Cash & equivalents$29.5M-10.5%
Total debt$263.7M-26.9%
Total equity$228.3M+41.6%
Total assets$673.3M-4.7%

Cash flow

See full
Operating cash flow$19.9M-23.4%
CapEx$960.0K+40.6%
Free cash flow$18.9M-25.1%

Valuation

See full
Market cap$1.17B+153%
Enterprise value$1.41B+78.0%
P/E21.6×
P/S+1.2×

Profitability

See full
Gross margin68.7%+1.1pp
Operating margin10%
Net margin9.4%+9.2pp
FCF margin16.2%+10.2pp

Returns & leverage

See full
Return on equity28%+27.5pp
Debt / equity1.2×-1.1×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Bioventus’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:43 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001665988-26-000042
Line itemJune 27, 2026December 31, 2025
Operating lease assets$4,225$5,122
Operating lease liabilities—other current liabilities$3,184$3,303
Operating lease liabilities—other long-term liabilities2,9254,456
Total operating lease liabilities$6,109$7,759
Property, plant and equipment, net$10,451$11,221
Finance lease liabilities—other current liabilities$960$907
Finance lease liabilities—other long-term liabilities8,2288,729
Total financing lease liabilities$9,188$9,636

Item 1. Financial Statements (Unaudited)

FAQ

What is Bioventus's operating lease liabilities (total)?
Bioventus (BVS) reported operating lease liabilities (total) of $6.11M in Q2 2026.
How has Bioventus's operating lease liabilities (total) changed year-over-year?
Bioventus's operating lease liabilities (total) decreased by 34.8% year-over-year, from $9.37M to $6.11M.
What is the long-term trend for Bioventus's operating lease liabilities (total)?
Over 5 years (2020 to 2025), Bioventus's operating lease liabilities (total) has grown at a -13.5% compound annual growth rate (CAGR), from $16.07M to $7.76M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Bioventus's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude